Table 47: Subjective Outcome Measures of Effectiveness. Transurethral Microwave Thermotherapy Versus TURP.
| Study, Year | IPSS, Mean (SD) | QOL score, Mean (SD) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Baseline | 3 months | 6 months | 12 months | > 1 year | Baseline | 3 months | 6 months | 12 months | > 1 year | |
| Wagrell et al. 2004 & 2002 (76;79) TUMT TURP |
21.0 (5.4) 20.4 (5.9) NR |
8.4 (5.5) 6.7 (4.3) P =NR |
7.4 (6.2) 5.9 (5) P =NR |
7.2 (6.2) 7.1 (6.6) P =.578 |
2 years: 7.2 (5.9) 4.6 (4.4) P = .014 3 years: 8.2 (6.9) 5.0 (3.9) P = .024 |
DANPSS-1 4.3 (1.0) 4.2 (1.1) NR |
DANPSS-1 1.5 (1.4) 1.1 (1.6) P =NR |
DANPSS-1 1.3 (1.4) 1.0 (1.5) P =NR |
DANPSS-1 1.4 (1.3) 1.5 (1.7) P =.972 |
2 years: 1.3 (1.2) 0.9 (1.3) P = .108 3 Years 1.2 (1.2) 1.0 (1.4) P = .162 |
| Norby et al. 2002 (56) TUMT TURP |
20.5 (5.7) 21.3 (6.6) P =.640 |
NR | 9.5 (7.1) 6.8 (5.7) P =.128 |
NR | NR | 4 4 P =.828 |
NR | 2 1 P =.055 |
NR | NR |
| Floratos, et al. 2001 TUMT TURP |
21 20 |
NR | NR | 8 3 |
2 years: TUMT: 9 TURP: 4 3 years TUMT: 12 TURP: 3 P = .000 |
4 4 |
NR | NR | 2 1 |
2 years TUMT: 2 TURP: 1 3 years TUMT: 2 TURP: 1 P ≤ .000 |
| Francisca, et al 2000 TUMT TURP |
20.1 (6.5) 20.8 (6.2) P = .57 |
10.5 (7.9) 5.3 (5.2) P < .01 |
NR | 7.6 (5.6) 3.2 (2.5) P < .01 |
NR |
Madsen symptom score 14.9 (4) 15.1 (4.1) P = .38 |
Madsen symptom score 6.4 (5.7) 3.5 (3.7) P < .01 |
NR |
Madsen symptom score 5.5 (4.6) 2.1 (2.1) P < .01 |
NR |
BPH refers to benign prostatic hyperplasia; DANPSS, Danish Prostatic Symptom Score; IPSS, International Prostate Symptom Score; NR, not reported; QOL, Quality of life; TUMT, transurethral microwave thermotherapy; TURP transurethral resection of the prostate